­Bora Pharmaceuticals to Acquire GSK’s Facility in Canada

 ­Bora Pharmaceuticals to Acquire GSK’s Facility in Canada

¬Bora Pharmaceuticals to Acquire GSK’s Facility in Canada

Shots:

  • Bora acquires GSK’s facility located in Mississauga, Ontario (Canada) which produces ~50 products and employs ~400 skilled manufacturing staff. The transaction is expected to be completed in H2’20
  • As per the transaction, GSK’s staff will join the Bora which will continue to manufacture the existing GSK’s product line for a minimum of five years. The facility will move to a new location within a timeframe, following the closure of the transaction
  • The acquisition will boost Bora’ technical capabilities & enables it to locally support its core markets of North America and Asia

Click here ­to­ read full press release/ article | Ref: Bora Pharmaceutical | Image: ­GSK

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post